Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial

Montemurro, F; Delaloge, S; Barrios, CH; Wuerstlein, R; Anton, A; Brain, E; Hatschek, T; Kelly, CM; Pena-Murillo, C; Yilmaz, M; Donica, M; Ellis, P

Montemurro, F (corresponding author), FPO IRCCS, Day Hosp Oncol Multidisciplinare, Candiolo Canc Inst, Str Prov 142, I-10060 Turin, Italy.

ANNALS OF ONCOLOGY, 2020; 31 (10): 1350